Clinical Trial Update: Differences in Atorvastatin Metabolite Ratios as a Diagnostic Tool in Detecting Atorvastatin Induced Myotoxicity [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating whether differences in atorvastatin metabolite ratios can diagnose atorvastatin-induced myotoxicity. The study, conduct…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Statin-induced Myopathy

Drugs mentioned

• atorvastatin (atorvastatin)

Snippet

Sponsor: Oslo University Hospital | Conditions: Muscular Diseases | Phase 4 | Status: COMPLETED